These findings have sparked considerable interest in exploring the therapeutic implications of ROS-mediated apoptosis as a mechanism for modulating PD-L1 expression and enhancing the effectiveness of cancer immunotherapy [22,23]. This evidence concerns the gene CD274 and cancer.